首页|贝那普利联合重组人脑利钠肽治疗充血性心力衰竭的效果

贝那普利联合重组人脑利钠肽治疗充血性心力衰竭的效果

扫码查看
目的:探究贝那普利联合重组人脑利钠肽治疗充血性心力衰竭的效果。方法:选取 2020 年 3 月—2023 年 3 月武汉市第一医院心血管内科接受治疗的 106 例充血性心力衰竭患者,按照随机数表法分为两组,各 53 例。单独组采用重组人脑利钠肽进行治疗,联合组采用贝那普利联合重组人脑利钠肽治疗。比较两组每搏输出量(SV)、心排血量(CO)、左心室射血分数(LVEF)、左室舒张末期内径(LVEDD)、去甲肾上腺素(NE)、内皮素-1(ET-1)、N末端B型利钠肽原(NT-proBNP)、白细胞介素-6(IL-6)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、可溶性细胞间粘附分子-1(sICAM-1)、促甲状腺激素(TSH)、三碘甲状腺原氨酸(T3),统计并比较两组治疗有效率和不良反应发生率。结果:治疗后,联合组SV、LVEF、T3、CO、治疗总有效率高于单独组,LVEDD、NE、ET-1、NT-proBNP、IL-6、CRP、TNF-α、sICAM-1 水平低于单独组,差异有统计学意义(P<0。05);两组TSH水平比较,差异无统计学意义(P>0。05)。联合组不良反应发生率高于单独组,差异无统计学意义(P>0。05)。结论:充血性心力衰竭患者采用贝那普利联合重组人脑利钠肽治疗,可改善心功能、血清神经激素因子水平,减轻炎症反应。
Effect of Benazepril Combined with Recombinant Human Brain Natriuretic Peptide in the Treatment of Congestive Heart Failure
Objective:To explore the effect of Benazepril combined with Recombinant Human Brain Natriuretic Peptide in the treatment of congestive heart failure.Method:A total of 106 patients with congestive heart failure who received treatment in the Cardiovascular Department of the First Hospital of Wuhan from March 2020 to March 2023 were selected and divided into two groups by random number table method,with 53 cases in each group.The single group was treated with Recombinant Human Brain Natriuretic Peptide,and the combined group was treated with Benazepril combined with Recombinant Human Brain Natriuretic Peptide.The stroke volume(SV),cardiac output(CO),left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD),noradrenaline(NE),endothelin-1(ET-1),N-terminal pro-brain natriuretic peptide(NT-proBNP),interleukin-6(IL-6),C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),soluble intercellular cell adhesion molecule-1(sICAM-1),thyroid stimulating hormone(TSH)and triiodothyronine(T3)between the two groups were compared,the effective rate and the incidence of adverse reactions were compared between the two groups.Result:After treatment,the levels of SV,LVEF,T3,CO and total effective rate in combined group were higher than those in single group,while the levels of LVEDD,NE,ET-1,NT-proBNP,IL-6,CRP,TNF-α and sICAM-1 were lower than those in single group,the differences were statistically significant(P<0.05).There was no significant difference in TSH level between the two groups(P>0.05).The incidence of adverse reactions in combined group was higher than that in single group,and the difference was not statistically significant(P>0.05).Conclusion:Patients with congestive heart failure treated with Benazepril combined with Recombinant Human Brain Natriuretic Peptide can improve cardiac function,serum levels of neurohormone factors and reduce inflammation.

BenazeprilRecombinant Human Brain Natriuretic PeptideCongestive heart failure

李方艳、郑苗、阮婧佳

展开 >

武汉市第一医院 湖北 武汉 430030

贝那普利 重组人脑利钠肽 充血性心力衰竭

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(3)
  • 23